Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,422 | -17,639 | -11,329 | -9,915 | -2,301 |
| Depreciation Amortization | 504 | 2,109 | 1,582 | 1,053 | 523 |
| Income taxes - deferred | N/A | 53 | N/A | N/A | N/A |
| Accounts receivable | -65 | 213 | 102 | -1,870 | -3,087 |
| Other Working Capital | -2,346 | 3,649 | 2,661 | -188 | -1,102 |
| Other Operating Activity | -1,174 | -323 | -1,606 | 3,114 | 1,465 |
| Operating Cash Flow | $-5,503 | $-11,938 | $-8,590 | $-7,806 | $-4,502 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,826 | 11,710 | 9,440 | 3,802 | -8,000 |
| PPE Investments | -60 | -149 | -157 | -133 | -38 |
| Purchase Sale Intangibles | 250 | -125 | -125 | -125 | N/A |
| Other Investing Activity | 250 | -125 | -125 | -125 | 0 |
| Investing Cash Flow | $-1,636 | $11,436 | $9,159 | $3,544 | $-8,038 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 24,322 | 2,483 | 692 | 77 | 1 |
| Other Financing Activity | 0 | -12,176 | -12,176 | -11,163 | -52 |
| Financing Cash Flow | $24,322 | $-9,693 | $-11,484 | $-11,086 | $-51 |
| Exchange Rate Effect | 0 | -103 | 11 | 3 | 5 |
| Beginning Cash Position | 19,999 | 30,296 | 30,296 | 30,296 | 30,296 |
| End Cash Position | 37,182 | 19,999 | 19,392 | 14,952 | 17,711 |
| Net Cash Flow | $17,184 | $-10,298 | $-10,904 | $-15,345 | $-12,585 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,503 | -11,938 | -8,590 | -7,806 | -4,502 |
| Capital Expenditure | -60 | -182 | -157 | -133 | -38 |
| Free Cash Flow | -5,562 | -12,119 | -8,746 | -7,938 | -4,540 |